The global Healthcare Contract Research Organization Market size is expected to reach USD 74.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2022 to 2030. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trial costs and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.
In addition, growing pressure on industry players to
follow stringent timelines has increased the demand for outsourcing research
activities to CROs. Some government organizations are also outsourcing their
clinical trial activities so that they can carry out clinical
trials with the required infrastructure, expertise, and minimize their
cost and timelines. The CRO market was temporarily affected by the ongoing
pandemic, as it led to the closure of clinical trial sites.
However, owing to the significant demand for
treatments, the clinical trial sites were reopened with certain measures and
precautions to avoid the spread of the virus. Moreover, the worldwide focus on
finding a vaccine against coronavirus has had a significant impact on
the development of vaccines & drugs for COVID-19. This is expected to have
a positive impact on the market. Owing to the pandemic, the players of the CRO
market built powerful tools to support virtual clinical trials, so as to
assist sponsors of the trials. Such actions are likely to improve market
growth.
Related Press Release@ Healthcare Contract Research Organization Market Report
Healthcare Contract Research
Organization Market Report Highlights
- Based on type, the clinical segment has dominated the market in
2021, with the largest share of 76.4%, owing to the fact that it comprises
four elaborate phases, including human subjects. The significant demand
for new treatments has further contributed to the growth of the segment
- Among services, the clinical monitoring segment was the largest in
terms of both the market share and revenue in 2021
- North America held a significant market share of 25.3% in 2021 due
to the presence of several global players, who invest a major part of
their revenue in research activities
- In Asia Pacific, the market is anticipated to witness lucrative
growth of 8.0% over the forecast period due to the reduced cost it offers
in comparison to the U.S and other developed economies
- China, Japan, and India are projected to witness tremendous growth
in the market over the forecast period owing to high disease prevalence in
these countries
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment